 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright reissued their buy rating on shares of Nuvation Bio (NYSE:NUVB  Free Report) in a research note released on Monday, Benzinga reports. HC Wainwright currently has a $4.50 price...

Nuvation Bio (NYSE:NUVB) Receives "Buy" Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Nuvation Bio (NYSE:NUVB  Free Report) in a research note released on Monday morning, Benzinga reports. The firm currently has a $4.50 target price on the stock. HC Wainwright also issued estimates for Nuvation Bios Q3 2023 earnings ...

Nuvation Bio (NYSE:NUVB) Earns "Buy" Rating from HC Wainwright

Nuvation Bio Inc. (NYSE:NUVB  Free Report)  Investment analysts at HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for Nuvation Bio in a research note issued on Monday, August 21st. HC Wainwright analyst R. Burns anticipates that the company will post earnings of...

Analysts Offer Predictions for Nuvation Bio Inc.'s Q1 2024 Earnings (NYSE:NUVB)

Nuvation Bio Inc. (NYSE:NUVB  Free Report)  Equities research analysts at HC Wainwright increased their Q3 2023 EPS estimates for shares of Nuvation Bio in a research report issued to clients and investors on Monday, August 21st. HC Wainwright analyst R. Burns now expects that the ...

Q3 2023 Earnings Estimate for Nuvation Bio Inc. (NYSE:NUVB) Issued By HC Wainwright

Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nuvation Bio (NUVB Research Report), Finch Therape... Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nuvation Bio (NUVB Research Report), Finch ...

Analysts Are Bullish on These Healthcare Stocks: Nuvation Bio (NUVB), Finch Therapeutics Group (FNCH)

Wedbush reaffirmed their outperform rating on shares of Nuvation Bio (NYSE:NUVB Free Report) in a research report released on Friday, RTT News reports. The brokerage currently has a $5.00 price objective on the stock. Nuvation Bio Stock Performance Shares of NUVB stock opened at $1.95 on Friday. ...

Nuvation Bio (NYSE:NUVB) Earns "Outperform" Rating from Wedbush

Nuvation Bio GAAP EPS of -$0.09 beats by $0.02

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the second quarter ended June 30, 2023, and provided a business update. 'We...

Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

AWM Investment Company Inc. boosted its position in Nuvation Bio Inc. (NYSE:NUVB  Get Rating) by 76.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 625,000 shares of the companys ...

Nuvation Bio Inc. (NYSE:NUVB) Shares Acquired by AWM Investment Company Inc.

AWM Investment Company Inc. boosted its position in Nuvation Bio Inc. (NYSE:NUVB Get Rating) by 76.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 625,000 shares of the companys stock after ...

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Watchers	697
52-Wk Low	$1.18
52-Wk High	$2.55

Market Cap	$307.92M
Volume (M)	400.00
52-Wk High	$2.55
52-Wk Low	$1.18

Current Price	$1.40
Prev Close	$1.33
Open	$1.35
Dividend Yield	0.00%
50-Day Moving Average	$1.68
Beta	1.12
Avg. Volume	369,551.96
PE Ratio	-3.38

52-Week High	$2.55
52-Week Low	$1.18
Market Capitalization	$307.92M
EPS	-$0.4136
Price to Book	0.49
Revenue Per Employee	N/A
Enterprise Value/EBITDA	2.20

NUVB Nuvation Bio Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals